Fasting and Cancer: What the Research Actually Says

Fasting and fasting-mimicking diets are being studied because they may influence glucose, insulin, growth signaling, inflammation, and stress-resistance pathways. Early research is interesting, but it is not a universal recommendation (Brandhorst et al., GeroScience, 2021).

Clinical studies suggest fasting-mimicking approaches may be feasible in carefully selected patients, but results are not definitive across cancer types and treatments. Safety depends on nutritional status, body weight, medications, treatment intensity, and disease stage (Valdemarin et al., Cancers, 2021).

Patients with unintended weight loss, cachexia, low BMI, eating disorder history, diabetes medications, pregnancy, poor oral intake, kidney disease, frailty, or intensive treatment schedules should not fast without medical guidance.

Instead of asking “Should I fast?” patients can ask, “Given my treatment, weight, labs, and goals, is any form of meal timing appropriate, or would it create risk?”

SANAVITA Health provides physician-led integrative oncology education and support with a focus on clarity, safety, whole-person care, and collaboration. The goal is to help patients understand their options, reduce avoidable risk, and build a supportive plan that fits their diagnosis, treatment phase, values, and care team recommendations.